| INTRODUC TI ON
Fetal vitamin D deficiency might have adverse effects on the developing lung and immune system, and subsequently influence lung function, and the risk of asthma and allergy in later life. 1, 2 Vitamin D deficiency during pregnancy may alter the expression of genes associated with asthma in children, 3 potentially through their roles in lung development and airway branching morphogenesis. 3, 4 Vitamin D might also have immunomodulatory effects in utero, including inhibition of fetal Th2 responses, which might affect the development of asthma and allergy in childhood. 5 A combined analysis of two randomized controlled trials showed that high-dose vitamin D supplementation in pregnancy reduced the risk of asthma with 26%
in pre-school children. 6 Three meta-analyses of prospective cohort studies on the associations of early life 25-hydroxyvitamin D concentrations with respiratory and allergy outcomes in children found inconsistent results. [7] [8] [9] One meta-analysis reported that lower and higher 25-hydroxyvitamin D concentrations during pregnancy were associated with an increased risk of childhood asthma, with the lowest risk at a 25-hydroxyvitamin D concentration of 70 nmol/L, 7 while others did not find consistent associations with asthma, 8, 9 lung function 9 or allergic sensitization. 9 However, studies included in these meta-analyses used only one single assessment of 25-hydroxyvitamin D at different time-points during pregnancy or at birth, or were not able to take child's 25-hydroxyvitamin D into account, 10 which may explain the inconsistency. We previously observed that lower 25-hydroxyvitamin D concentrations at birth were associated with a higher airway resistance in children aged 6 years, adjustment for child's 25-hydroxyvitamin D reduced the effect size. 11 We hypothesized that altered 25-hydroxyvitamin D concentrations in critical periods of early life are associated with adverse childhood respiratory and allergy outcomes. Therefore, we examined among 4951 children and their mothers participating in a population-based prospective cohort study, whether 25-hydroxyvitamin D concentrations in mid-gestation and at birth were associated with lung function, asthma, inhalant allergic sensitization and inhalant allergy in school-age children. Additionally, we examined whether these associations could be explained by child's 25-hydroxyvitamin D concentrations at the age of 6 years.
| ME THODS

| Design and cohort
This study was embedded in the Generation R Study, a population-based prospective cohort study from early fetal life until young adulthood in Rotterdam, the Netherlands. A detailed description of the study design has been published previously. 12 The study has been approved by the Medical Ethical Committee of Erasmus MC, University Medical Centre in Rotterdam, the Netherlands (MEC-2012-165-NL40020.078.12). Written informed consent was obtained from the parents or legal representatives of all participating children. A total of 7393 children were participating at the age of 10 years. Twins (n = 185), and children of whom we had no data on 25-hydroxyvitamin D concentrations in mid-gestation or at birth (n = 1171), and children with missing data on lung function, asthma, inhalant allergic sensitization or inhalant allergy at age 10 years (n = 1086) were excluded. This resulted in 4951 mothers and their children for the current analyses ( Figure S1 ). . 15 When the children had a median age of 6.0 years (95% range 5.6-7.6 years), blood samples were collected. Child's 25-hydroxyvitamin D concentrations were measured at the Endocrine Laboratory of the VU University Medical Center, Amsterdam, using isotope dilution online solid phase extraction LC-MS/MS, which has been previously described in detail. 16 at the age of 6 years was available in a subgroup of 2809 subjects.
| 25-Hydroxyvitamin D
FVC and FEF 75 remained. We did not find consistent associations of 25-hydroxyvitamin D concentrations at birth with respiratory or allergy outcomes. cat or dog (ALK-Abelló BV, Almere, the Netherlands) was measured by skin prick tests using the scanned area method. 21 We used two positive controls (histamine dihydrochloride 10 mg/mL) and one negative control (sodium chloride 9 mg/mL). Skin responses were considered positive if the area of the wheal was ≥40% of that of the histamine response (ie histamine equivalent prick index area ≥0.40). 21 Contraindications for a skin prick test were eczema on the volar surface of the left forearm, the use of oral prednisone ≥10 mg daily, antihistamine intake <72 hours prior to the test or use of corticosteroid ointment ≤48 hours prior to the test.
Conclusion and clinical relevance:
| Covariates
Information on maternal age, body mass index at enrolment (BMI), educational level, history of asthma or atopy, psychiatric symptoms defined using the Global Severity Index (GSI), 22, 23 
| Statistical analysis
A non-response analysis was performed by comparing subject characteristics between children included and not included in the analyses by independent sample t test for continuous normally distributed . 18 We tested for multicollinearity using the tolerance statistic.
As tolerance was >0.20 for all variables in our models, there were no problems of multicollinearity. We applied natural cubic splines 
| RE SULTS
| Subject characteristics
Maternal and child characteristics are shown in Table 1 were not included in the analyses on average had mothers who were younger, had a higher BMI, were lower educated, were less often nulliparous, had less often pets and had lower folate concentrations in early pregnancy, and the children had more often not a Dutch or
Western ethnic background compared to children included in the analyses (P-value < 0.05) (Table S1 ). Non-response analyses comparing children with and without information on 25-hydroxyvitamin D concentrations at the age of 6 years most importantly showed that there was no difference in 25-hydroxyvitamin D concentrations in mid-gestation and at birth between the two groups (Table S2) . 
| 25-hydroxyvitamin D concentrations, respiratory and allergy outcomes
| D ISCUSS I ON
In this population-based prospective cohort study, we observed that 
| Comparison with previous studies
We One cohort study, which was included in the meta-analysis, measured maternal 25-hydroxyvitamin D concentrations at a similar time-point in pregnancy, mid-gestation, as we did and showed that higher maternal 25-hydroxyvitamin D concentrations in mid-gestation were associated with a higher FVC and a tendency towards a lower FEV 1 /FVC and FEF 25%-75% in 260 children aged 6 years. 25 The directions of the effect estimates in our study were similar.
Cohort studies within the meta-analysis that examined maternal However, an additional meta-analysis pooled studies with 164-3177 children and found that lower and higher maternal 25-hydroxyvitamin D concentrations taken at any time in pregnancy were associated Physician-diagnosed inhalant allergy at the age of 10 y, yes (%)
(369)
Values are means (SD), a medians (2.5-97.5th percentile) or valid percentages (absolute numbers), based on imputed data. Data on 25-hydroxyvitamin D in mid-gestation (n = 444), at birth (n = 1667), at the age of 6 y (n = 2142), and forced expiratory volume in 1 s (FEV 1 ) (n = 752), forced vital capacity (FVC) (n = 752), FEV 1 /FVC ratio (n = 752), forced expiratory flow after exhaling 75% of FVC (FEF 75 ) (n = 752), current asthma (n = 1001), inhalant allergic sensitization (n = 1512) and physician-diagnosed inhalant allergy (n = 2173) was not imputed.
TA B L E 1 (Continued)
TA B L E 2 Associations of 25-hydroxyvitamin D concentrations in mid-gestation with respiratory and allergy outcomes at age 10 y with a higher risk of asthma in children. 7 A combined analysis of two randomized controlled trials showed that women who received daily a high dose of vitamin D supplementation (4000 IU/d or 2400 IU/d) from a gestational age ranging from 10 to 26 weeks onwards had, compared to the control group of women who received placebo, a 26% reduced risk of a child with asthma/recurrent wheeze at the age of 3 years. 6 The meta-analyses and randomized controlled trials mostly assessed asthma at a young age, which more likely could reflect viral induced wheezing. 30 Our study additionally shows the long-term effects of maternal 25-hydroxyvitamin D concentrations in mid-gestation and at birth on asthma in children, which was not present.
We However, our study showed no effect of maternal 25-hydroxyvitamin D concentrations at birth on child's respiratory outcomes.
| Interpretation of the results
Aside and increased airway eosinophilia. 40 In five-week-old mice, results seemed different. 41 The association of higher 25-hydroxyvitamin D concentrations in mid-gestation with physician-diagnosed inhalant allergies attenuated after adjustment for 25-hydroxyvitamin D concentrations at the age of 6 years. Additional research to the underlying mechanism at different time-points during immune system development is needed.
| Strengths and limitations
The strengths of our study include that it was embedded in a prospective population-based cohort study with a large sample-size, and with detailed measurements on 25-hydroxyvitamin D concentrations at several time-points in early life, and on respiratory and allergy outcomes. We were able to adjust our models for multiple confounders, and additionally for 25-hydroxyvitamin D levels at the age of 6 years. The adjustment for folate concentration and maternal psychiatric symptoms might be tenuous. However, omitting these two confounders from our statistical models did not change our results (data not shown). We also need to men- gested that all pregnant women should be advised to take 10 µg of vitamin D daily. 46 Unfortunately, we had no detailed information on the intake of vitamin D from supplements for the current analyses and therefore cannot examine this potential effect on the observed associations. However, the observed 25-hydroxyvitamin D concentrations in mid-gestation and at birth are consistent with previous Dutch studies. 47 ,48
| CON CLUS ION
Our results suggest that, after additional adjustment for 25-hydroxy- Randomized controlled trials focusing on the effect of vitamin D supplementation in pregnancy or even pre-conceptional on long-term respiratory or allergy outcomes might be subject for further study.
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